StratifAI Joins With MSK iHub Challenge Cohort to Advance Validation of Polaris™ Through Access to World-Class Clinical Datasets

BERLIN & NEW YORK--(BUSINESS WIRE)--StratifAI, the AI precision oncology company behind the Polarisâ"¢ platform, today announced its selection for the Memorial Sloan Kettering (MSK) iHub Challenge 2025 Cohort program. This engagement will provide StratifAI with access to MSK's extensive clinical datasets and the opportunity to collaborate directly with leading clinicians and researchers to accelerate validation of its Polarisâ"¢ platform. Building a new standard in biomarker validation For decades,. ...